SOCS3 and colorectal carcinoma: As a critical negative regulator of the JAK/STAT signaling pathway, SOCS3 inhibits proliferation, migration, and invasion by blocking STAT3 activation, which is critical for lymph node metastasis and advanced clinical stages of CRC [28–31, 38].